Platinum on the road: Interactions of antitumoral cisplatin with proteins

被引:54
作者
Arnesano, Fabio [1 ]
Natile, Giovanni [1 ]
机构
[1] Univ Bari, Dipartimento Farmacochim, I-70125 Bari, Italy
关键词
platinum; anticancer drugs; cellular transport; proteins; DNA;
D O I
10.1351/pac200880122715
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
When the antitumor activity of cisplatin was discovered, no one Would have thought of the existence of specific proteins able to transport Pt across the cell membrane or to specifically recognize DNA modified by this drug. However, such proteins do exist and. furthermore, are specific for the Pt substrate considered. It follows that proteins are deeply involved in managing, the biological activity of cisplatin. It is expected that, after the first 20 years in which most of the efforts were devoted to understanding its mode of interaction with DNA and consequent structural and functional alterations, the role of proteins will be more deeply scavenged. How cisplatin can survive the attack of the many platinophiles present in the extracellular and intracellular media is the issue addressed in this article. Significantly, differences are observed between cisplatin, carboplatin, and oxaliplatin.
引用
收藏
页码:2715 / 2725
页数:11
相关论文
共 73 条
[31]   Cisplatin binding sites on human albumin [J].
Ivanov, AI ;
Christodoulou, J ;
Parkinson, JA ;
Barnham, KJ ;
Tucker, A ;
Woodrow, J ;
Sadler, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (24) :14721-14730
[32]   Mets motif peptide found in copper transport proteins selectively binds Cu(I) with methionine-only coordination [J].
Jiang, JF ;
Nadas, IA ;
Kim, MA ;
Franz, KJ .
INORGANIC CHEMISTRY, 2005, 44 (26) :9787-9794
[33]  
Katano K, 2002, CANCER RES, V62, P6559
[34]   Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer [J].
Kavanagh, JJ ;
Gershenson, DM ;
Choi, H ;
Lewis, L ;
Patel, K ;
Brown, GL ;
Garcia, A ;
Spriggs, DR .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (04) :593-600
[35]   The resurgence of platinum-based cancer chemotherapy [J].
Kelland, Lloyd .
NATURE REVIEWS CANCER, 2007, 7 (08) :573-584
[36]   OVEREXPRESSION OF METALLOTHIONEIN CONFERS RESISTANCE TO ANTICANCER DRUGS [J].
KELLEY, SL ;
BASU, A ;
TEICHER, BA ;
HACKER, MP ;
HAMER, DH ;
LAZO, JS .
SCIENCE, 1988, 241 (4874) :1813-1815
[37]   Reaction of Zn7Metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes:: trans-PtII complexes retain their N-donor ligands [J].
Knipp, Markus ;
Karotki, Andrei V. ;
Chesnov, Serge ;
Natile, Giovanni ;
Sadler, Peter J. ;
Brabec, Viktor ;
Vasak, Milan .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) :4075-4086
[38]  
Komatsu M, 2000, CANCER RES, V60, P1312
[39]   MOLMOL: A program for display and analysis of macromolecular structures [J].
Koradi, R ;
Billeter, M ;
Wuthrich, K .
JOURNAL OF MOLECULAR GRAPHICS, 1996, 14 (01) :51-&
[40]   NMR and mutagenesis of human copper transporter 1 (hCtr1) show that Cys-189 is required for correct folding and dimerization [J].
Lee, Sangwon ;
Howell, Stephen B. ;
Opella, Stanley J. .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2007, 1768 (12) :3127-3134